LAWRENCE STEINMAN - 02 Nov 2021 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Chris Vasquez, as Attorney-in-Fact for Lawrence Steinman
Issuer symbol
BCAB
Transactions as of
02 Nov 2021
Transactions value $
-$13,500
Form type
4
Filing time
03 Nov 2021, 17:09:39 UTC
Previous filing
05 Oct 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Sale -$13.5K -450 -2.38% $30.00* 18.5K 02 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.